Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
David Cordani, chairman and CEO of The Cigna Group, joined CNBC’s Mad Money for an interview with host Jim Cramer, where the two discussed the promise of biosimilars as well as our organization's strategy for pharmacy benefits management.
May 9, 2023 -
The healthcare outlook for 2023 and beyond has a number of encouraging trends for employers who provide health insurance to employees and their families. Read on to learn about four top healthcare topics and how they will impact American businesses.
- Healthcare Expertise
- Affordability
- Digital Health
- Healthier Communities
- Pharmacy Care
- Workforce Health & Well-Being
Dec 19, 2022 -
As promising biosimilar therapies to treat inflammatory conditions become available next year, Cigna Pharmacy, which manages pharmacy benefits for some Cigna clients, is announcing that it will add biosimilars as preferred products on its commercial formularies at the same position as Humira.
Dec 5, 2022 -
Cigna has found that the average annual price of therapy for specialty drugs is $38,000 per patient, which is 75 times higher than non-specialty prescription drugs.
Nov 4, 2022 -
Two years ago, Cigna Corporation created Evernorth – an organization dedicated to making health care better. Today, we’re celebrating our successes and looking forward to the future.
- Healthcare Expertise
- Affordability
- Digital Health
- Pharmacy Care
- Whole Person Health
- Workforce Health & Well-Being
Sep 29, 2022